FMII
BMRN icon

Farmers & Merchants Investments Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.44K Hold
165
– – ﹤0.01% 806
2026
Q1 		$9.32K Hold
165
– – ﹤0.01% 793
2025
Q4 		$9.81K Hold
165
– – ﹤0.01% 755
2025
Q3 		$8.94K Buy
165
+15
+10% +$858 ﹤0.01% 780
2025
Q2 		$8.25K Buy
150
+18
+14% +$1.06K ﹤0.01% 769
2025
Q1 		$9.33K Buy
132
+62
+89% +$4.17K ﹤0.01% 707
2024
Q4 		$4.6K Hold
70
– – ﹤0.01% 828
2024
Q3 		$4.92K Buy
70
+20
+40% +$1.67K ﹤0.01% 823
2024
Q2 		$4.12K Buy
+50
New +$4.16K ﹤0.01% 829

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Farmers & Merchants Investments Inc's BMRN Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 165 shares worth $9.44K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

Farmers & Merchants Investments Inc first reported a position in BMRN in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.81K in Q4 2025. 309 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Farmers & Merchants Investments Inc held 165 shares of BioMarin Pharmaceuticals worth $9.44K as of Q2 2026.
  • Farmers & Merchants Investments Inc left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #806 holding.
  • Farmers & Merchants Investments Inc first reported a position in BioMarin Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Farmers & Merchants Investments Inc's BioMarin Pharmaceuticals position peaked at $9.81K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.